Squamous cell carcinomas fail to respond to the prodifferentiating actions of 1,25(OH)2D: why?

Recent results in cancer research. Fortschritte der Krebsforschung. Progrès dans les recherches sur le cancer

Volumn 164, Issue , 2003, Pages 111-122

  Bikle, Daniel D ^a   Xie, Zhongjian ^a   Ng, Dean ^a   Tu, Chia Ling ^a   Oda, Yuko ^a  

^a UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

1,25-DIHYDROXYVITAMIN D; CALCITRIOL; DRIP, VDR INTERACTING PROTEIN COMPLEX; DRUG DERIVATIVE; NUCLEAR PROTEIN; TRANSACTIVATOR PROTEIN; VDRIP PROTEIN, HUMAN; VITAMIN D;

ANIMAL; CELL DIFFERENTIATION; DRUG EFFECT; HUMAN; METABOLISM; PATHOLOGY; REVIEW; SQUAMOUS CELL CARCINOMA;

ANIMALS; CARCINOMA, SQUAMOUS CELL; CELL DIFFERENTIATION; HUMANS; NUCLEAR PROTEINS; TRANS-ACTIVATORS; VITAMIN D;

MLCS; MLOWN;

EID: 0642367265     PISSN: 00800015     EISSN: None     Source Type: Journal    
DOI: 10.1007/978-3-642-55580-0_7     Document Type: Review

References (36)